#National Institutes of Health

Breakthrough findings from NIH study could lead to more effective prevention and treatment strategies.

NIH-funded study suggests need to boost CD8+ T cell response after infection.

With further development, the gel could provide additional protection against COVID-19 and other respiratory illnesses.

Worldwide, TB is one of the leading causes of death for people with HIV.

NIH-supported studies show variations in symptoms and diagnostic experiences among different racial and ethnic groups.

Many adults experience problems like coughing, chest pain, and fatigue six months after their stay.

Increased protection against hospitalization or death was seen regardless of age or history of previous boosters.

These data are consistent with a recent study reporting expansion was not associated with an increase in methadone-involved overdose deaths.

Ozone and fine particulate matter are associated with non-viral asthma attacks in children and adolescents in low-income urban areas.

Researchers halt the Mosaico study after an experimental vaccine was found to be safe but not effective against HIV.

The findings, if confirmed in humans, suggest strategies to help encourage people to exercise.

Berks County, Pennsylvania, is the first community to join a partnership with local public health departments.

The antiviral treatment reduced the risk of hospitalization or death from SARS-CoV-2 Omicron variants in older adults by 44%.

Scientists will test community-based approaches to prevent drug overdoses and curb high death rates.

The new director of the National Cancer Institute says her prognosis is very favorable.

Current guidelines recommend antiviral treatment regardless of alcohol use.